Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reisa Sperling

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Annals of the New York Academy of Sciences|April 7, 2007
Functional MRI studies of associative encoding in normal aging, mild cognitive impairment, and Alzheimer's diseaseReisa Sperling
Neurobiology of Aging|November 15, 2011
Potential of functional MRI as a biomarker in early Alzheimer's diseaseReisa Sperling
Alzheimer'S Research & Therapy|July 1, 2010
Pro: Can biomarkers be gold standards in Alzheimer's disease?Reisa Sperling, Keith Johnson
Continuum (Minneapolis, Minn.)|April 6, 2013
Biomarkers of Alzheimer disease: current and future applications to diagnostic criteriaReisa Sperling, Keith Johnson
Cell|October 17, 2023
Accelerating Alzheimer's therapeutic development: The past and future of clinical trialsAdam L Boxer, Reisa Sperling
Neuron|December 3, 2014
The evolution of preclinical Alzheimer's disease: implications for prevention trialsReisa Sperling, Elizabeth Mormino, Keith Johnson
Science Translational Medicine|December 23, 2011
Mapping the road forward in Alzheimer's diseaseDavid M Holtzman, Alison Goate, Jeffrey Kelly, et al.
Brain : a Journal of Neurology|June 27, 2013
In vivo characterization of the early states of the amyloid-beta networkJorge Sepulcre, Mert R Sabuncu, Alex Becker, et al.
Annals of Clinical and Translational Neurology|April 22, 2020
The A4 study: β-amyloid and cognition in 4432 cognitively unimpaired adultsPhilip S Insel, Michael C Donohue, Reisa Sperling, et al.
Journal of Alzheimer'S Disease : JAD|November 10, 2018
Clinical Evaluation of Amyloid-Related Imaging Abnormalities in Bapineuzumab Phase III StudiesH Robert Brashear, Nzeera Ketter, Jennifer Bogert, et al.
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Annals of the New York Academy of Sciences|April 7, 2007
Functional MRI studies of associative encoding in normal aging, mild cognitive impairment, and Alzheimer's diseaseReisa Sperling
Neurobiology of Aging|November 15, 2011
Potential of functional MRI as a biomarker in early Alzheimer's diseaseReisa Sperling
Alzheimer'S Research & Therapy|July 1, 2010
Pro: Can biomarkers be gold standards in Alzheimer's disease?Reisa Sperling, Keith Johnson
Continuum (Minneapolis, Minn.)|April 6, 2013
Biomarkers of Alzheimer disease: current and future applications to diagnostic criteriaReisa Sperling, Keith Johnson
Cell|October 17, 2023
Accelerating Alzheimer's therapeutic development: The past and future of clinical trialsAdam L Boxer, Reisa Sperling
Neuron|December 3, 2014
The evolution of preclinical Alzheimer's disease: implications for prevention trialsReisa Sperling, Elizabeth Mormino, Keith Johnson
Science Translational Medicine|December 23, 2011
Mapping the road forward in Alzheimer's diseaseDavid M Holtzman, Alison Goate, Jeffrey Kelly, et al.
Brain : a Journal of Neurology|June 27, 2013
In vivo characterization of the early states of the amyloid-beta networkJorge Sepulcre, Mert R Sabuncu, Alex Becker, et al.
Annals of Clinical and Translational Neurology|April 22, 2020
The A4 study: β-amyloid and cognition in 4432 cognitively unimpaired adultsPhilip S Insel, Michael C Donohue, Reisa Sperling, et al.
Journal of Alzheimer'S Disease : JAD|November 10, 2018
Clinical Evaluation of Amyloid-Related Imaging Abnormalities in Bapineuzumab Phase III StudiesH Robert Brashear, Nzeera Ketter, Jennifer Bogert, et al.
Pageof 10